Back to AVTX

Affinity Asset Advisors, LLC → AVTX

Affinity Asset Advisors, LLC AVTX Position History

Avalo Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$49.7M
Q3 2026
Peak value
$53.6M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$19.1M
Q1 2026$20M
Q2 2026$53.6M
Q3 2026$49.7M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$49.7M3.24M——
Q2 2026$53.6M2.90M——
Q1 2026$20M1.34M——
Q4 2025$19.1M1.05M——

Other funds holding AVTX

Other Affinity Asset Advisors, LLC positions

ROIV

ROIVANT SCIENCES LTD

$132.7M
APGE

APOGEE THERAPEUTICS INC

$131M
ROIV

ROIVANT SCIENCES LTD

$117M
SYRE

SPYRE THERAPEUTICS INC

$113.9M
SYRE

SPYRE THERAPEUTICS INC

$113.6M
APGE

APOGEE THERAPEUTICS INC

$108.2M
XENE

XENON PHARMACEUTICALS INC

$97.4M
XENE

XENON PHARMACEUTICALS INC

$96.3M